An approach of immunoneurological aspects in nasal allergic late phase

Allergy and Asthma Proceedings

Volumn 26, Issue 5, 2005, Pages 382-390

  Jordan, Thorsten R ^a   Rasp, Gerd ^a   Pfrogner, Elisabeth ^a   Kramer, Matthias F ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 5; LEUKOTRIENE C4; RNASE3 PROTEIN, HUMAN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; FEMALE; HAY FEVER; HUMAN; IMMUNOMODULATION; MALE; METABOLISM; MUCUS; NOSE PROVOCATION TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; RHINOMETRY; TIME;

ADULT; AUTONOMIC NERVOUS SYSTEM; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; INTERLEUKIN-5; LEUKOTRIENE C4; MALE; MUCUS; NASAL PROVOCATION TESTS; NEUROIMMUNOMODULATION; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; RHINOMETRY, ACOUSTIC; TIME FACTORS;

EID: 27644491083     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy 41:37-47, 1978.
2. Pipkorn U. Hay fever: In the laboratory and at natural allergen exposure. Allergy 8:41-44, 1988.
3. de Graaf-in't V, Koenders S, Garrelds IM, et al. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 98:508-513, 1996.
4. Hilberg O, Jackson AC, Swift DL, et al. Acoustic rhinometry: Evaluation of nasal cavity geometry by acoustic reflection. J Appl Physiol 66:295-303, 1989.
5. Hilberg O, Jensen FT, and Pedersen OF. Nasal airway geometry: Comparison between acoustic reflections and magnetic resonance scanning. J Appl Physiol 75:2811-2819, 1993.
6. Eccles R. Sympathetic control of nasal erectil tissue. Eur Respir J 64:150f, 1983.
7. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 146:170-176, 1992.
8. Kramer MF, Ostertag P, Pfrogner E, et al. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 110:1056-1062, 2000.
9. Venge P. Soluble markers of allergic inflammation. Allergy 49:1-8, 1994.
10. Durham SR. The inflammatory nature of allergic disease. Clin Exp Allergy 28(suppl 6):20-24, 1998.
11. Henderson WRJ, Lewis DB, Albert RK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 184:1483-1494, 1996.
12. Marom Z, Shelhamer JH, Bach MK, et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 126:449-451, 1982.
13. Gibson PG, Manning PJ, O'Byrne PM, et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis 143:331-335, 1991.
14. Kobayashi H, Gleich GJ, Butterfield JH, et al. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 99 99:2214-2220, 2002.
15. Terada N, Konno A, and Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 94:629-642, 1994.
16. Undem BJ, Kajekar R, Hunter DD, et al. Neural integration and allergic disease. J Allergy Clin Immunol 106(5 suppl):S213-S220, 2000.
17. Kramer MF, Ostertag P, Pfrogner E, et al. Nasal IL-16 and MIP-1 alpha in late-phase allergic response. Allergy Asthma Proc 22:127-132, 2001.
18. van Adelsberg J, Philip G, LaForce C, et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 90:214-222, 2003.
19. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 32:1020-1028, 2002.
20. Jackson AC, Butler JP, Millet EJ, et al. Airway geometry by analysis of acoustic pulse response measurements. J Appl Physiol 43:523-536, 1977.
21. Rasp G. Acoustic rhinometry: Measuring the early and late phase of allergic immediate reaction in allergic rhinitis. Laryngorhinootologie 72:125-130, 1993.
22. Zweiman B, Getsy J, Kalenian M, et al. Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge. J Allergy Clin Immunol 100:624-631, 1997.
23. Klimek L, and Rasp G. Norm values for eosinophil cationic protein in nasal secretions: Influence of specimen collection. Clin Exp Allergy 29:367-374, 1999.
24. Wang D, and Clement P. Assessment of early and late-phase nasal obstruction in atopic patients after nasal allergen challenge. Clin Otolaryngol 20:368-373, 1995.
25. Iliopoulos O, Proud D, Adkinson NF, et al. Relationship between the early and late, and rechallenge reaction to nasal challenge with antigen: Observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 86:851-861, 1990.
26. Lebel B, Bousquet J, Morel A, et al. Correlation between the symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 82:869-877, 1988.
27. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 105:S599-S604, 2000.
28. Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol 113:88-814, 2004.
29. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99:S763-S772, 1997.
30. Scott RB, Tan DT, Miampamba M, et al. Anaphylaxis-induced alterations in intestinal motility: Role of extrinsic neural pathways. Am J Physiol 275:G812-G821, 1998.
31. Schumacher MJ, and Pain MC. Nasal challenge testing in grass pollen hay fever. J Allergy Clin Immunol 64:202-208, 1979.
32. Richerson HB, Rajtora DW, Penick GD, et al. Cutaneous and nasal allergic responses in ragweed hay fever: Lack of clinical and histopathologic correlations with late phase reactions. J Allergy Clin Immunol 64:67-77, 1979.
33. Dvoracek JE, Yunginger JW, Kern EB, et al. Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. J Allergy Clin Immunol 73:363-368, 1984.
34. Eccles R, Reilly M, and Eccles KS. Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol 116:77-81, 1996.
35. Eccles RB. The nasal cycle in respiratory defense. Acta Otorhinolaryngol Belg 54:281-286, 2000.
36. Lund VJ. Nasal physiology: Neurochemical receptors, nasal cycle, and ciliary action. Allergy Asthma Proc 17:179-184, 1996.
37. Sanico AM, Koliatsos VE, Stanisz AM, et al. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis. Int Arch Allergy Immunol 118:154-158, 1999.
38. Miadonna A, Milazzo N, Gibelli S, et al. Nasal response to a single antigen challenge in patients with allergic rhinitis - Inflammatory cell recruitment persists up to 48 hours. Clin Exp Allergy 29:941-949, 1999.
39. Mosmann TR, and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996.
40. Greenfeder S, Umland SP, Cuss FM, et al. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res 2:71-79, 2001.
41. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10:471-480, 1994.
42. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med 179:703-708, 1994.
43. Kramer MF, and Rasp G. Nasal polyposis: Eosinophils and interleukin-5. Allergy 54:669-680, 1999.
44. Ohnishi T, Sur S, Collins DS, et al. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J Allergy Clin Immunol 92:607-615, 1993.
45. Miadonna A, Tedeschi A, Leggieri E, et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 136:357-362, 1987.
46. Raphael GD, Meredith SD, Baraniuk JN, et al. The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 139:791-800, 1989.
47. Mullol J, Raphael GD, Lundgren JD, et al. Comparison of human nasal mucosal secretion in vivo and in vitro. J Allergy Clin Immunol 89:584-592, 1992.
48. Drazen JM, Austen KF, Lewis RA, et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 77:4354-4358, 1980.
49. Bisgaard H, Olsson P, and Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance, and nasal secretions in humans. Clin Allergy 16:289-297, 1986.
50. Shirasaki H, Kanaizumi E, Watanabe K, et al. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 32:1007-1012, 2002.
51. Frieri M, Therattil J, Wang SF, et al. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma. Allergy Asthma Proc 24:359-366, 2003.
52. Underwood DC, Osborn RR, Newsholme SJ, et al. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: Modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 154:850-857, 1996.
53. Howarth PH. Leukotrienes in rhinitis. Am J Respir Crit Care Med 161:S133-S136, 2000.
54. McAlexander MA, Myers AC, and Undem BJ. Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. J Pharmacol Exp Ther 285:602-607, 1998.
55. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 88(4 suppl 1): 16-22, 2002.